Agilent Technologies Launches Gene Expression Microarray Platform
Agilent Technologies, Inc. has introduced a new gene expression microarray platform designed to offer researchers flexibility and precision in studying genetic activity across various organisms.
Agilent Technologies, Inc. has unveiled a new gene expression microarray platform aimed at assisting researchers in the analysis of gene activity. The platform is designed to provide enhanced flexibility and accuracy in collecting and interpreting genetic data for scientific studies.
The platform supports a range of applications, including the use of gene expression and exon microarrays. Agilent offers customized solutions tailored for different organism groups, such as humans, animals, bacteria, fungi, and plants, intending to equip researchers with versatile tools for biological research.
The system also encompasses necessary reagents, buffers, and software for data analysis, reflecting Agilent's commitment to providing comprehensive solutions that enable scientists to focus on discovery. The company also manufactures the required scanning equipment for the microarrays.
This technology can be applied to understand disease mechanisms, identify potential drug targets, and advance fundamental biological research. Microarray analysis remains a key methodology in genomics and molecular biology.